Granich Reuben, Gupta Somya, Hall Irene, Aberle-Grasse John, Hader Shannon, Mermin Jonathan
International Association of Providers of AIDS Care, Washington, D.C., United States of America.
Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS Med. 2017 Apr 4;14(4):e1002253. doi: 10.1371/journal.pmed.1002253. eCollection 2017 Apr.
In 2014, the Joint United Nations Program on HIV/AIDS (UNAIDS) issued treatment goals for human immunodeficiency virus (HIV). The 90-90-90 target specifies that by 2020, 90% of individuals living with HIV will know their HIV status, 90% of people with diagnosed HIV infection will receive antiretroviral treatment (ART), and 90% of those taking ART will be virally suppressed. Consistent methods and routine reporting in the public domain will be necessary for tracking progress towards the 90-90-90 target.
For the period 2010-2016, we searched PubMed, UNAIDS country progress reports, World Health Organization (WHO), UNAIDS reports, national surveillance and program reports, United States President's Emergency Plan for AIDS Relief (PEPFAR) Country Operational Plans, and conference presentations and/or abstracts for the latest available national HIV care continuum in the public domain. Continua of care included the number and proportion of people living with HIV (PLHIV) who are diagnosed, on ART, and virally suppressed out of the estimated number of PLHIV. We ranked the described methods for indicators to derive high-, medium-, and low-quality continuum. For 2010-2016, we identified 53 national care continua with viral suppression estimates representing 19.7 million (54%) of the 2015 global estimate of PLHIV. Of the 53, 6 (with 2% of global burden) were high quality, using standard surveillance methods to derive an overall denominator and program data from national cohorts for estimating steps in the continuum. Only nine countries in sub-Saharan Africa had care continua with viral suppression estimates. Of the 53 countries, the average proportion of the aggregate of PLHIV from all countries on ART was 48%, and the proportion of PLHIV who were virally suppressed was 40%. Seven countries (Sweden, Cambodia, United Kingdom, Switzerland, Denmark, Rwanda, and Namibia) were within 12% and 10% of achieving the 90-90-90 target for "on ART" and for "viral suppression," respectively. The limitations to consider when interpreting the results include significant variation in methods used to determine national continua and the possibility that complete continua were not available through our comprehensive search of the public domain.
Relatively few complete national continua of care are available in the public domain, and there is considerable variation in the methods for determining progress towards the 90-90-90 target. Despite bearing the highest HIV burden, national care continua from sub-Saharan Africa were less likely to be in the public domain. A standardized monitoring and evaluation approach could improve the use of scarce resources to achieve 90-90-90 through improved transparency, accountability, and efficiency.
2014年,联合国艾滋病规划署(UNAIDS)发布了人类免疫缺陷病毒(HIV)的治疗目标。90-90-90目标规定,到2020年,90%的HIV感染者将知晓自己的HIV感染状况,90%确诊感染HIV的人将接受抗逆转录病毒治疗(ART),90%接受ART治疗的人病毒载量将得到抑制。在公共领域采用一致的方法和常规报告对于跟踪实现90-90-90目标的进展情况至关重要。
在2010 - 2016年期间,我们检索了PubMed、UNAIDS国家进展报告、世界卫生组织(WHO)、UNAIDS报告、国家监测和项目报告、美国总统艾滋病紧急救援计划(PEPFAR)国家业务计划以及会议报告和/或摘要,以获取公共领域中最新的可用国家HIV治疗连续体信息。治疗连续体包括已确诊、接受ART治疗以及病毒载量得到抑制的HIV感染者人数及其在估计的HIV感染者总数中所占的比例。我们对用于指标的描述方法进行排名,以得出高、中、低质量的连续体。对于2010 - 2016年,我们确定了53个有病毒载量抑制估计数据的国家治疗连续体,这些数据代表了2015年全球HIV感染者估计数的1970万(54%)。在这53个连续体中,有6个(占全球负担的2%)质量较高,采用标准监测方法得出总体分母,并使用国家队列的项目数据来估计治疗连续体中的各个步骤。撒哈拉以南非洲只有9个国家有病毒载量抑制估计的治疗连续体。在这53个国家中,所有国家接受ART治疗的HIV感染者总数的平均比例为48%,病毒载量得到抑制的HIV感染者比例为40%。七个国家(瑞典、柬埔寨、英国、瑞士、丹麦、卢旺达和纳米比亚)在“接受ART治疗”和“病毒载量抑制”方面分别距离实现90-90-90目标的比例在12%和10%以内。在解释结果时需要考虑的局限性包括用于确定国家治疗连续体的方法存在显著差异,以及通过我们对公共领域的全面检索可能无法获取完整的连续体信息。
公共领域中可获取的完整国家治疗连续体相对较少,并且在确定朝着90-90-90目标进展的方法上存在很大差异。尽管撒哈拉以南非洲承担着最高的HIV负担,但其国家治疗连续体在公共领域出现的可能性较小。一种标准化的监测和评估方法可以通过提高透明度、问责制和效率,更好地利用稀缺资源来实现90-90-90目标。